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Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416 A415effects on chondrocyte hypertrophy, the use of PPS as an anti-hyper-
trophy and anti-dedifferentiation factor could provide themuch desired
chondrocyte phenotype stability for cartilage engineering using MSCs
as opposed to PSGAG that promoted a ﬁbrocartilage phenotype. The
expression of type II collagen and aggrecan in the absence of Sox-9
further showed that other transcription factors interacting either
directly or indirectly with HIF-2a may be involved in the regulation of
the cartilage-speciﬁc proteins.
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Purpose: Traumatic injuries around the knee joint can result in the
formation of defects within the articular cartilage. These defects do not
heal spontaneously, and can initiate a degenerative process, eventually
resulting in osteoarthritis (OA), a chronic and debilitating disease that
affects over 4.5 million Canadians. Current cartilage repair options are
limited and do not result in the regeneration of durable cartilage. Tissue
engineered cartilage constructs (TECCs) implanted into a defect site have
been shown to contribute to cartilage repair, thereby providing a
potential approach to prevent the onset, or the progression of OA. TECCs
have traditionally been formed in the wells of static culture plates by
inoculating ahighdensityofmesenchymal stemcells (MSCs) into serum-
containing medium. Unfortunately, TECCs made in tissue culture plates
can exhibit some variable characteristics, most importantly the tissue
contraction and biochemical composition of the tissue. Such variability
can likely also be exacerbated by the use of animal-sourced serum in the
medium, which is known to vary from batch-to-batch. Therefore, a need
still exists to better optimize the generationof uniformTECCs to enhance
the clinical translatability of this otherwise promising technology. Scal-
able suspension culture bioreactors have demonstrated an ability to
stimulate the aggregation other stem cell lineages, and thus may be
beneﬁcial in the generation of cell-matrix aggregates suitable for carti-
lage repair. As the environment in a suspension bioreactor can be com-
puter-controlled at an optimized level, it may result in the production of
TECCs that are more uniform in size, shape and composition to repair
different types of cartilage defects.
Methods: Human synovial ﬂuid-derived MSCs were isolated and cul-
tured under serum-free conditions in two-dimensional static culture
ﬂasks. Two different methods were evaluated for aggregating MSCs to
form TECCs in dynamic suspension bioreactors. In the ﬁrst method,
MSCs were inoculated into suspension bioreactors as single cells and
allowed to aggregate. In the secondmethod, MSCswere ﬁrst aggregated
by pelleting the cells and then the resultant aggregates were inoculated
into suspension bioreactors. TECCs resulting from the suspension cul-
ture methods were analyzed for cell proliferation, size distribution and
extracellular matrix (ECM) deposition. The results were compared to
the size distribution and ECM deposition of the TECCs formed in the
static culture ﬂasks. Furthermore, the TECCs formed in suspension
culture and static culture ﬂasks underwent subsequent growth factor
conditioning (TGF-Beta, BMP-2, ascorbic acid, dexamethasone) to
identify the combination of growth factors that optimized extracellular
matrix deposition to that more closely resembling native cartilage. The
type of proteins produced in the ECMwere evaluated by histochemistry
for glycosaminoglycans and immunohistochemistry for collagen type I,
II, X, ﬁbronectin and lubricin. Furthermore, cell death within the
aggregates was determined using a ﬂuorescence cell viability assay.
Results: Human synovial ﬂuid-derived MSCs were successfully isolated
and grown under serum-free conditions. By comparing the uniformity
of the aggregates (see ﬁgure below), the composition of the ECM and
the extent of cell death inside the aggregates produced using the two
bioreactor production methods investigated, a single method for pro-
ducing uniform populations of TECCs in a dynamic suspension bio-
reactor environment has been identiﬁed.Subsequently, the aggregates produced in suspension bioreactors were
exposed to a combination of growth factors previously shown to induce
chondrogenesis inMSCs. Therefore, a combination of growth factors has
been identiﬁed that resulted in TECCs with an up regulated articular
cartilage phenotype (see immunolocalization of collagen II in the ﬁgure
below).
Conclusions: The use of bioreactor technology and deﬁned serum-free
medium will facilitate the production of uniform populations of TECCs.
Such TECCs can further be conditioned with chondrogenic growth
factors to enhance their chondrogenic phenotype. TECCs produced
using scalable bioreactors may prove to be capable of repairing cartilage
defects of different sizes by using a varying numbers of aggregates to
repair the defect.
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Purpose: Nowadays tissue-engineering laboratories are actively
assessing new materials that could improve or enhance outcomes in
current cell-based methods. More speciﬁcally, for cartilage tissue
regeneration there are increasing publications with new materials
Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416A416(e.g. hydrogels, sponges, membranes) but in vivo testing presents
several challenges. The most realistic in vivo models are based in large
animal models (e.g. ovine, porcine, equine). However, housing and
maintenance of large animals is expensive and the number of animals
in most studies lack statistical power and robustness resulting in
reduced scientiﬁc information. Murine and laprine in vivo models
have been developed as alternative to bypass such limitations. Nev-
ertheless, the major drawbacks of these models for cartilage repair
studies are their spontaneous cartilage healing. The aim of this work
was the development of a new screening in vivo model that could be
useful in tissue engineering. The in vivo screening model would
provide a tool to validate new materials or cell treatments before large
animals studies.
Methods: Six mm diameter wide, four mm high osteochondral biopsies
were harvested from swine knee joints (N¼6). Half of the samples
received a four mm diameter chondral injury without disturbing the
subchondral bone. The rest of the samples were left undamaged.
Afterwards, both type of biopsies were implanted subcutaneously into
seven weeks old immunodeﬁcient Rag2 mice (Balb/cA Rag2-/- gC-/-),
two plugs per animal, 3 mice. These implants were maintained in the in
vivo model for 6 weeks. The survival of the osteochondral plugs was
evaluated macroscopically and with H&E stainingResults:Macroscopically all the implanted osteochondral plugs showed
high vascularization after 6 weeks and maintained original size and
shape (Figure 1). The vascularization enabled the viability of the bone
part of the osteochondral plug. Besides, new bone grown over dead
bone containing empty lacunae was apparent suggesting active osteo-
genesis (2A). Moreover, it was possible identiﬁed the presence of
osteoclast and lining osteoblast that indicates normal bone remodeling
mostly, although such activity developed in the upper part of the plug
(Figure 2B). In undamaged plugs, the cartilage layer showed an unal-
tered structure and the presence of hypertrophy was not observed
(Figure 2C). Articular cartilage that received chondral injury did not
show spontaneous repair
Conclusions: Osteochondral plugs with and without chondral lesion
maintain their vitality in the cartilaginous as well as in the subchondral
bone layer when they are implanted ectopically into immunodeﬁcient
animals. Thus, we demonstrate the feasibility of the use of osteochon-
dral for the evaluation of biomaterials. Therefore, it is possible minimize
the use of expensive and valuable large animal models by pre-testing
biomaterials in an osteochondral plug using an ectopic implantation
model.
